Combined Inositol Hexakisphosphate and Inositol Supplement Consumption Improves Serum Alpha-Amylase Activity and Hematological Parameters in Streptozotocin-Induced Type 2 Diabetic Rats

Table 1

Organ weights of diabetic rats treated with combined IP6 and inositol supplement or glibenclamide.

Mean weights	NC	HFC	DC	IP6 + INO	Glib
Liver (g)	10.7 ± 0.31^a	10.2 ± 0.35^a	11.1 ± 0.45^a	11.0 ± 0.37^a	11.2 ± .19^a
Relative liver wt. (%)	3.02 ± 0.56^a	2.78 ± 0.07^a	3.78 ± 0.13^b	3.61 ± 0.14^b	3.38 ± 0.13^b
Kidney (g)	1.18 ± 0.02^a	1.2 ± 0.07^a	1.52 ± 0.09^b	1.45 ± 0.06^b	1.44 ± 0.04^b
Relative kidney wt. (%)	0.33 ± 0.01^a	0.33 ± 0.01^a	0.51 ± 0.03^b	0.47 ± 0.03^b	0.44 ± 0.03^b
Spleen (g)	0.67 ± 0.03^a	0.69 ± 0.06^a	0.63 ± 0.05^a	0.60 ± 0.03^a	0.60 ± 0.03^a
Heart (g)	1.36 ± 0.06^a	1.32 ± 0.05^a	1.30 ± 0.05^a	1.35 ± 0.51^a	1.31 ± 0.47^a
Pancreas (g)	1.33 ± 0.1^a	1.56 ± 0.1^a	0.93 ± 0.09^b	0.97 ± 0.07^b	0.84 ± 0.06^b

Note. Data are shown as mean ± S.E.M. The mean values in a row with different superscript letters are significantly different at , as assessed by Duncan’s multiple range test. Relative organ wt.% = (organ weight (g)/body wt (g)) ×100. NC, normal control; HFC, high-fat control; DC, diabetic untreated control; IP6 + INO, combined IP6 and inositol.